Pharma Journalist -

Nektar Therapeutics announced that Takeda signed the research collaboration agreement with Nektar Therapeutics through its wholly-owned subsidiary, Millennium Pharmaceuticals to enter…
Read More...

PCI Biotech and RXi Pharmaceuticals announced that they are extending their preclinical research collaboration initiated on April 7, 2015. The preclinical research collaboration will…
Read More...

EMA (European Medicines Agency) has recommended to grant a marketing authorisation in the European Union (EU) for a new ATMP (advanced therapy medicinal product) to treat adult patients…
Read More...

The EMA (European Medicines Agency) has recommended grant for marketing authorisation in the European Union (EU) for Oxervate (cenegermin) to treat neurotrophic keratitis. Oxervate is a…
Read More...

Sanofi announced that the CHMP (Committee for Medicinal Products for Human Use) of the EMA (European Medicines Agency) recommended the use of Insulin lispro Sanofi (insulin lispro 100…
Read More...

Amgen announced that it has submitted the BLA (Biologics License Application) for Erenumab along with the data from pivotal studies in patients with episodic and chronic migraine to the…
Read More...

Astellas Pharma President and CEO, Yoshihiko Hatanaka announced that they have completed the acquisition of Ogeda SA (Ogeda) and now it has become a wholly owned subsidiary of Astellas…
Read More...

Pharmadax announced that U.S. FDA has approved the generic equivalent of Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg, launched by Pharmadex in…
Read More...

Pharmaceutical Product Development (PPD) has expanded its vaccine sciences lab in Richmond, Virginia, to enhance its ability so as to provide industry-leading capabilities to meet…
Read More...

Aduro Biotech announced the expansion of its clinical collaboration with Merck to include an additional Phase 2 clinical trial to evaluate the combination of CRS-207, Aduro’s LADD…
Read More...